On Jul. 2, 2020, the National Medical Product Administration (#NMPA) and the National Health Commission (NHC) published the 2020 Edition of the #Pharmacopoeia of the People's Republic of #China, which came into force on Dec. 30, 2020. All finished pharmaceutical products with China's #marketing authorization shall meet the technical requirements of dosage forms, test methods, guidelines, etc., in the Chinese Pharmacopoeia since Dec. 30, 2020. Chinese Pharmacopoeia 2020 English Version has been available since Mar. 14, 2023. Contact📞 BaiPharm if you'd like to get access to the English version. https://baipharm.chemlinked.com/news/china-issued-the-2020-edition-of-chinese-pharmacopoeia